%0 Journal Article
%B American Heart Journal
%D 2004
%F NMHjournal
%G eng
%L Y
%P 52-61.[IF 3.649]
%T Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination, in high risk patients: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telm
%V 148
%! Am Heart J
%&  3.649